Stalfort John A III (CIK 1709418) reported 4 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-06-05). Recent activity: Buy ABOS (35,500 shares), Buy TSHA (21,335 shares), Buy ABOS (12,800 shares), Buy TSHA (56,623 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-05 | Acumen Pharmaceuticals, Inc. (ABOS) | Director | Buy | 35,500 | $0 |
| 2026-06-02 | Taysha Gene Therapies, Inc. (TSHA) | Director | Buy | 21,335 | $0 |
| 2025-06-05 | Acumen Pharmaceuticals, Inc. (ABOS) | Director | Buy | 12,800 | $0 |
| 2025-06-04 | Taysha Gene Therapies, Inc. (TSHA) | Director | Buy | 56,623 | $0 |
Source: SEC Form 4 filings · as of 2026-06-05